Location: Home
  • search
  • go
  • Relate News
  • 12/18/2018Grifols Eyes $5B Takeover of Shanghai RAAS Blood Products
  • 12/17/2018I-Mab and CSPC Pharma Announce Strategic Alliance for Long-acting GLP-...
  • 12/17/2018Roche Wins Chinese Approval of Anticancer Perjeta (Pertuzumab)
  • 12/17/2018NMPA Seeks Comments on the Second List of Drugs with Expired, Terminat...
  • 12/14/2018Recent Official and Executive Moves
  • 12/14/2018NHC Set to Launch National Adjuvant Drug List Soon
  • 12/13/2018Promising Phase 3 Results For Green Valley’s Alzheimer’s Drug
  • 12/13/2018JW Therapeutics Opens R&D Center in Shanghai
  • 12/13/2018Innovent Announces Positive Outcome of Two Clinical Studies for Avasti...
  • 12/13/2018WuXi AppTec Failed to Shine on HKEx Debut
  • 12/12/2018Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. Just ...
  • 12/11/2018HitGen and Mitsubishi Tanabe Pharma Enter Discovery Research Partnersh...
  • 12/11/2018UCB Announces Chinese Approval of Seizure Drug VIMPAT
  • 12/10/2018WuXi AppTec Expands Site in California for Pharmaceutical R&D ...
  • 12/9/2018Gilead Launches HBV Drug Vemlidy in China
  • 12/7/2018National Centralized Drug Purchase Trial Upsets Pharma Industry with C...
  • 12/7/2018Recent Executive Moves
  • 12/7/2018SAMR Fines Three Violators as It Steps Up Anti-monopoly Crackdown on A...
  • 12/7/2018State Council Approves Patent Amendment Draft and Policies to Boost In...
  • 12/7/2018Oral Insulin Moves Towards Becoming Reality in U.S., China
  • 12/7/2018IFPMA and RDPAC Introduce New Code for Pharmaceutical Marketing Practi...
  • 12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...
  • 12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite
  • 12/5/2018NMPA Approves Gilead's HIV Combo Drug Descovy
  • 12/5/2018Insurer Manulife-Sinochem Inks Deal with Healthcare Platform 111 Inc.
  • 12/5/2018Innovent Gains US FDA Approval to Initiate Clinical Trials for its Ant...
  • 12/5/2018China Approves New Indication of J&J's Prostate Cancer Drug ZYTIGA
  • 12/4/2018Revance Licenses China Rights of Neuromodulator RT002 to Fosun Pharma
  • 12/4/2018Roche’s Hemlibra (emicizumab) Approved for Import and Marketing in Ch...
  • 12/4/2018SMEI President Predicts Continued Chinese Pharma Growth in 2019
  • Page:153/360 Total number of articles:10791: [First][<<] [151] [152] [153] [154] [155] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group